Lurasidone for the treatment of schizophrenia in adult and paediatric populations

JUAN LUIS PRADOS OJEDA2026-01-292026-01-29202310.7573/dic.2022-10-12-s2.0-85148457973https://www.scopus.com/inward/record.uri?eid=2-s2.https://ucocris.uco.es/handle/123456789/36074Medicine (all)PharmacologyLurasidone for the treatment of schizophrenia in adult and paediatric populationsreview article